Solstice Advanced Materials, Inc. (SOLS) Earnings Call Transcripts

8 earnings calls from October 2025 to July 30, 2026

NasdaqGS US Materials Chemicals

Solstice Advanced Materials, Inc.'s Latest Earnings Call - June 4, 2026

In the Q2 2026 earnings call for Solstice Advanced Materials, Inc. (SOLS:US), management highlighted a robust growth outlook for their nuclear business, which is now a significant driver of revenue following the spin-off from Honeywell. The company reported a nuclear backlog of approximately $2.2 billion and expects to produce over 10 kilotons of uranium hexafluoride (UF6) in 2026, a 20% increase from planned output in 2024. Management maintained guidance for double-digit adjusted EBITDA CAGR through 2030, emphasizing strong demand dynamics and pricing power in the nuclear conversion market.

Reported metrics

MetricValueContext
Revenue $300M (beat) vs $290M est, +26.2% YoY
Backlog $2.2B (positive) reflects firm contracts with 90% minimum volume commitments
Production Capacity 10 kilotons (positive) represents a 20% increase vs planned 2024 output
Adjusted EBITDA CAGR double-digit (positive) expected through 2030
Contract Pricing Increase $20 (positive) increase over the past few years due to tightening supply/demand
Investment in Modernization $100M (positive) invested since 2022 to enhance Metropolis Works facility

Guidance from management

Management maintained guidance for double-digit adjusted EBITDA CAGR through 2030, supported by a strong backlog and increasing demand for nuclear conversion services.

What management said

Thanks, John. I appreciate the question. We haven't given direct pricing guidance on any specific business, so I won't go into that. As you did mention, we do have good visibility based on the UXC pricing contract, and I think that's a good indicator of where we see pricing going over the next few years as we come forward. Beyond that, again, we aren't going into the specific margin profiles or anything like that w...
— Jeffrey Dormo, June 4, 2026 earnings call
Yes. As I think about the overall earnings growth within the business, we've talked about double-digit EBITDA growth previously, and that's something that we continue to have high confidence in delivering on.
— Jeffrey Dormo, June 4, 2026 earnings call

What analysts pressed on

Analysts expressed concerns about the pace of cost growth relative to pricing increases and the potential for new competitors entering the UF6 market. There were questions regarding how these dynamics might impact margins and overall profitability in the coming years.

Main topics on the call

Read the full Solstice Advanced Materials, Inc. transcript (June 4, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Solstice Advanced Materials, Inc.

Solstice Advanced Materials, Inc. (SOLS) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 8 calls on record spanning October 8, 2025 to July 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 8 Solstice Advanced Materials, Inc. earnings call transcripts on record, spanning October 8, 2025 to July 30, 2026. Based on this history, Solstice Advanced Materials, Inc. reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SOLS
Exchange
NasdaqGS
Country
US
Sector
Materials
Industry
Chemicals
Calls on record
8
First call
October 8, 2025
Most recent
July 30, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 30, 2026 Read transcript
Special Calls Jun 4, 2026 Read transcript
Q1 FY2026 May 6, 2026 Read transcript
Company Conference Presentations Feb 19, 2026 Read transcript
Q4 FY2025 Feb 11, 2026 Read transcript
Company Conference Presentations Dec 4, 2025 Read transcript
Q3 FY2025 Nov 6, 2025 Read transcript
Analyst/Investor Day Oct 8, 2025 Read transcript